Metpride MP 2mg/500mg/15mg Tablet SR
Marketer
Assure Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metpride MP 2mg/500mg/15mg Tablet SR
Glucoprime-MP 2mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This regimen, alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and schedule for Glucoprime-MP 2mg/500mg/15mg ER Tablets; take with food to prevent gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, omit the missed dose and resume the regular schedule. Never double the dose. Overdosage can cause hypoglycemia. Concurrent use with other antidiabetic agents, alcohol, or skipped meals may increase hypoglycemia risk; frequent blood sugar monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor prior to use if you have kidney, liver, or heart conditions, or are pregnant/breastfeeding. Kidney function tests will be performed before treatment initiation. Limit alcohol consumption as it may heighten adverse effects.
Primary Ingredients of Metpride MP 2mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Metpride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metpride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metpride MP 2mg/500mg/15mg Sustained-Release tablet should be administered with food.
Common Side effects of Metpride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metpride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metpride MP 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
How Metpride MP 2mg/500mg/15mg Tablet SR works:
Metpride MP tablets (2mg/500mg/15mg sustained-release) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood sugar management when single or dual therapies prove insufficient. Glimepiride (a sulfonylurea) stimulates pancreatic insulin release to reduce blood glucose. Metformin (a biguanide) acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and boosting insulin sensitivity. Pioglitazone (a thiazolidinedione) further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metpride MP 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Metpride MP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Metpride MP tablets (2mg/500mg/15mg) are likely not suitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Metpride MP 2mg/500mg/15mg SR tablets; dosage modification may be necessary. Consult your physician for guidance. Metpride MP 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Metpride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Metpride MP 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metpride MP 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Metpride MP 2mg/500mg/15mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metpride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently